Peripheral IV Access for Chemo Better Than Central Lines in Testicular Cancer?
Patients with testicular cancer had fewer venous access-related complications and overall thrombotic events when first-line chemotherapy was delivered via peripheral intravenous access compared with central venous access devices (CVADs), a retrospective study suggested. Among 154 patients, those in the CVAD group compared with the peripheral IV group experienced more venous access-related complications (52.2% vs 24.2%) […]
Risk of Premature Death Seen in Testicular Cancer Survivors
Treating testicular cancer (TC) with platinum-based chemotherapy (PBCT) and radiotherapy (RT) was associated with an increased risk of long-term non-TC mortality, a Norwegian population-based cohort study found. Over a median follow-up of 18.7 years, overall excess non-TC mortality was 23% in men diagnosed with TC compared with the general population (standardized mortality ratio [SMR] 1.23, […]
Study Confirms, Clarifies Excess Mortality in Testicular Cancer Survivors
Platinum-based chemotherapy (PBCT) and radiation therapy (RT) for testicular cancer significantly increased the risk of premature death from other causes, especially secondary cancers, a large Norwegian study showed. Overall, the 5,700 men included in the analysis had a 23% excess mortality from causes other than testicular cancer after treatment with PBCT or RT, as compared […]